Project Manager (Oncology)
ICON plc
Summary
As a Project Manager, you will be the primary liaison to your clients, ensuring questions are answered and issues are resolved. You work together with other project leaders and vendors to keep your projects running at optimal quality - on time and on budget - managing all project deliverables, with financial acumen and a risk mitigation mindset. As a project leader, you provide feedback to your team to help improve overall performance.
Job description
Job Responsibilities
- Act as primary liaison with clients.
- Lead and direct cross-functional team leaders and third parties/vendors with some supervision and support.
- Manage project contractual deliverables, including progress via metrics and adherence to contractual agreement time, quality/scope, and cost deliverables.
- Participation and attendance in bid defense process.
- Provide feedback on project team members’ performance to respective line-managers.
- Maintain detailed understanding of each functional service area and lead multifaceted functional teams effectively with little supervision or support.
- Develop in depth analysis and projections of project timelines and financials for senior and customer management with little to no supervision.
What do you need to have?
- Minimum of 3 years’ experience in clinical research within a CRO
- Undergraduate degree or its international equivalent from an accredited institution or an equivalent combination of education and experience sufficient to successfully perform the key responsibilities of this job, required
- Undergraduate degree in clinical, science, or health-related field, preferred
- Licensed healthcare professional (i.e., registered nurse), preferred
- Minimum 1-2 years of experience leading Oncology cellular therapy clinical trials, strongly preferred.
- English fluency (ability to read, write, speak), required
- Travel of up to 25% is required for this position. Exact amounts of travel will vary, pending client needs.
Requirements
- Minimum of 3 years’ experience in clinical research within a CRO
- Undergraduate degree or its international equivalent from an accredited institution or an equivalent combination of education and experience sufficient to successfully perform the key responsibilities of this job, required
- Undergraduate degree in clinical, science, or health-related field, preferred
- Licensed healthcare professional (i.e., registered nurse), preferred
- Minimum 1-2 years of experience leading Oncology cellular therapy clinical trials, strongly preferred.
- English fluency (ability to read, write, speak), required
- Travel of up to 25% is required for this position. Exact amounts of travel will vary, pending client needs.
Benefits
- Competitive base salary
- Performance related incentives
- Medical, Dental & Vision
- Retirement plans
- Pension plans
- Life assurance
- Disability coverage
- Employee assistance programmes
- Wellbeing resources
- Learning and development opportunities
Company overview
ICON plc is a global leader in clinical research and healthcare intelligence, founded in Dublin, Ireland in 1990. As one of the world's largest contract research organizations (CROs), ICON provides comprehensive outsourced development services to pharmaceutical, biotechnology, and medical device companies worldwide. The company operates in 55 countries with approximately 41,900 employees, offering end-to-end solutions that span the entire product development lifecycle. ICON's service portfolio includes clinical research services, adaptive trials, biosimilars, commercialization and outcomes consulting, medical imaging, laboratory services, and strategic support for traditional and digital health technologies. The company specializes in therapeutic areas such as oncology, cardiovascular diseases, central nervous system disorders, rare diseases, and women's health. With its 2021 acquisition of PRA Health Sciences, ICON significantly expanded its capabilities and market position, becoming a dominant force in the global CRO industry. The company is publicly traded on NASDAQ under the ticker ICLR and reported $8.28 billion in revenue for 2024.